Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis

Oral Janus kinase inhibitors (JAKi) are increasingly used in dermatology, rheumatology, gastroenterology, and hematology. While effective, they can cause adverse effects such as acne, nausea, cytopenia, dyslipidemia, and Herpes zoster. Recent reports have linked JAKi usage to weight changes, particu...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Grace Xiong, BHSc, Eric Yu, Martin Heung, Jaehyeong Yang, BSc, Megan Lowe, MPH, Mohannad Abu-Hilal, MD
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2025-04-01
Цуврал:	JAAD International
Нөхцлүүд:	abrocitinib baricitinib Janus kinase inhibitors medical dermatology ruxolitinib tofacitinib
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2666328724001871
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!